Intermittent drug dosing intervals guided by the operational multiple dosing half lives for predictable plasma accumulation and fluctuation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology
Link
http://link.springer.com/content/pdf/10.1007/s10928-011-9198-0.pdf
Reference23 articles.
1. Sahin S, Benet LZ (2008) The operational multiple dosing half-life: a key to defining drug accumulation in patients and to designing extended release dosage forms. Pharm Res 25:2869–2877
2. Boxenbaum H, Battle M (1995) Effective half-life in clinical pharmacology. J Clin Pharmacol 35:763–766
3. Hamby DM (1994) A review of techniques for parameter sensitivity analysis of environmental models. Environ Monit Assess 32:135–154
4. Perucca E, Gatti G, Frigo GM, Crema A, Calzetti S, Visintini D (1978) Disposition of sodium valproate in epileptic patients. Br J Clin Pharmacol 5:495–499
5. Dutta S, Reed RC, O’Dea RF (2006) Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets—clinical implications. Ann Pharmacother 40:619–625
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Optimizing gefitinib nanoliposomes by Box-Behnken design and coating with chitosan: A sequential approach for enhanced drug delivery;ADMET and DMPK;2024-07-31
2. Clinical Development of PROTACs;PROTAC-Mediated Protein Degradation: A Paradigm Shift in Cancer Therapeutics;2024
3. In vivo degradation forms, anti-degradation strategies, and clinical applications of therapeutic peptides in non-infectious chronic diseases;European Journal of Pharmacology;2022-10
4. Azithromycin concentration in rabbits’ plasma and posterior segment of the eyes following oral drug administration: a dose-finding study for the application in ocular toxoplasmosis;Journal of Pharmacy and Pharmacology;2022-10-01
5. An innovative study design with intermittent dosing to generate a GLP-regulatory package in preclinical species for long lasting molecule M5717, inhibitor of Plasmodium eukaryotic translation elongation factor 2;Toxicology and Applied Pharmacology;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3